These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31074017)

  • 21. Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series.
    Ribeiro MC; de Mattos Camargo Grossmann S; do Amaral MBF; de Castro WH; Navarro TP; Procopio RJ; da Silva TA; de Nazaré Alves de Oliveira Kato C; Mesquita RA
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):900-907. PubMed ID: 29329829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sclerotherapy followed by surgery for the treatment of oral hemangioma: a report of two cases.
    Mariano FV; Vargas PA; Della Coletta R; Lopes MA
    Gen Dent; 2011; 59(3):e121-5. PubMed ID: 21903533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?
    Kato CN; Ribeiro MC; Abreu MH; Grossmann SD; Abreu LG; Caldeira PC; Mesquita RA
    Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e468-e473. PubMed ID: 32388528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
    Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
    Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center.
    Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W
    Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient satisfaction after sclerotherapy of venous malformations in children.
    Nakahata K; Uehara S; Zenitani M; Nakamura M; Osuga K; Okuyama H
    Pediatr Int; 2016 Aug; 58(8):721-5. PubMed ID: 26662951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five adult laryngeal venous malformation cases treated effectively with sclerotherapy.
    Kamijo A; Hatsushika K; Kanemaru S; Moriyama M; Kase Y; Masuyama K
    Laryngoscope; 2013 Nov; 123(11):2766-9. PubMed ID: 23553378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonographic follow-up of ethanolamine oleate sclerotherapy for hydrocele.
    Mattila SI; Tammela TL; Mäkäräinen HP; Hellström PA
    J Ultrasound Med; 1993 Jun; 12(6):311-5. PubMed ID: 8515526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
    Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
    Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success.
    Khaitovich B; Kalderon E; Komisar O; Eifer M; Raskin D; Rimon U
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1695-1701. PubMed ID: 31538233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
    Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
    Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes and complications of sclerotherapy for venous malformations.
    Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
    Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional sclerotherapy for subcutaneous venous malformations in children.
    Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
    Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.
    Johann AC; Aguiar MC; do Carmo MA; Gomez RS; Castro WH; Mesquita RA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Nov; 100(5):579-84. PubMed ID: 16243243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
    Kitagawa A; Izumi Y; Hagihara M; Kamei S; Ikeda S; Katsuda E; Kimura J; Ota T; Ishiguchi T
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):371-80. PubMed ID: 23737022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sclerotherapy for Venous Malformations of the Pharynx or the Tongue Base Without Tracheostomy: Treatment Protocol With Intubation and Outcomes.
    Iwashina Y; Ozaki M; Wong M; Ihara A; Fujiki M; Takushima A; Harii K
    J Craniofac Surg; 2020; 31(3):702-706. PubMed ID: 32149978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.